CN Patent
CN103694168B — 一种6-氯-4-三氟甲基-3-氰基吡啶的制备方法
Assigned to GUIZHOU WYLTON JINGLIN ELECTRONIC MATERIAL CORP · Expires 2015-08-19 · 11y expired
What this patent protects
本发明公开了一种6-氯-4-三氟甲基-3-氰基吡啶的制备方法,包括如下步骤:2-氯-6-甲氧基-4-三氟甲基-3-氰基吡啶的合成;6-甲氧基-4-三氟甲基-3-氰基吡啶的合成;6-羟基-4-三氟甲基-3-氰基吡啶的合成;6-氯-4-三氟甲基-3-氰基吡啶的合成。本发明产率高,反应步骤短,操作简单,高效易行。
USPTO Abstract
本发明公开了一种6-氯-4-三氟甲基-3-氰基吡啶的制备方法,包括如下步骤:2-氯-6-甲氧基-4-三氟甲基-3-氰基吡啶的合成;6-甲氧基-4-三氟甲基-3-氰基吡啶的合成;6-羟基-4-三氟甲基-3-氰基吡啶的合成;6-氯-4-三氟甲基-3-氰基吡啶的合成。本发明产率高,反应步骤短,操作简单,高效易行。
Drugs covered by this patent
- Rinvoq (upadacitinib) · AbbVie Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.